Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy.
Overview & Synopsis
Open access biomedical research article published in Front Immunol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy. |
|---|---|
| Author / Organization | Riabinska A, Criado-Moronati E, Balta E, Frison D, Berganza-Irusqueta C, Telatar T, Maciaczyk D, Engeln J, Fischer L, Domdey M, Siddiqui I, Miranda V, Schmidt T, Kebir S, Ahmadipour Y, Glas M, Herrlinger U, Schneider M, Potthoff AL, Czabanka M, Broggini T, Stenqvist S, Nilsson LM, Nilsson JA, Ott M, Dzionek A, Hardy IR |
| Subject & Discipline | Front Immunol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-120652 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |